Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes
This study is testing a program called the AURORA Care Strategy to help younger Latinx adults (ages 21-44) who have been recently diagnosed with type 2 diabetes (T2D). The program involves three telemedicine (video or phone) visits with a care navigator who provides personalized support for managing T2D. To join, you need to be a Kaiser Permanente Northern California member with a new T2D diagnosis within the last 1-8 months and a specific blood sugar level (HbA1c of 8% or higher, or potentially 7.5% or higher). You also need to be able to speak and write in English or Spanish. The study will look at whether this support helps improve blood sugar levels (HbA1c) after 6 months. The current recruitment status is unclear.
- Study design
- This is an interventional study planning to enroll 204 participants. It will compare the AURORA Care Strategy to standard care.
- What's involved
- Participants will have three telemedicine visits with a care navigator during the months following their diagnosis. The study will measure blood sugar levels (HbA1c) at 6 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants' blood sugar levels will be measured 6 months after they join the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Anjali Gopalan, MD, MS · PRINCIPAL_INVESTIGATOR · Kaiser Permanente
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Differences between study arms in HbA1c change 6-months following enrollment6-months following enrollment
Change in HbA1c will be assessed using HbA1c values obtained through routine care, with the most recent HbA1c preceding study enrollment and the HbA1c value closest to 6-months following enrollment used to assess HbA1c change.